BCL2L1 and congestive heart failure: Another characteristic of this CD4+CD28null population is its resistance to apoptosis (54, 55) this is corroborated by the increased expression of the BCL2 and BCL2L1 genes, antiapoptotic molecules, in CHF CMV+ patients.